Attached files

file filename
EX-99.1 - EXHIBIT 99.1 - ASSEMBLY BIOSCIENCES, INC.v456522_ex99-1.htm

  

 

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

  

FORM 8-K

 

 

  

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): January 9, 2017

 

 

  

ASSEMBLY BIOSCIENCES, INC.

(Exact name of Registrant as Specified in Its Charter)

 

 

  

Delaware   001-35005   20-8729264
(State or Other Jurisdiction
of Incorporation)
  (Commission
File Number)
  (IRS Employer Identification No.)

 

11711 N. Meridian Street, Suite 310

Carmel, Indiana 46032

(Address of principal executive offices, including zip code)

 

(317) 975-2694

(Registrant’s telephone number, including area code)

 

 

  

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):

 

¨Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

  

Item 7.01. Regulation FD Disclosure

 

Assembly Biosciences, Inc. (the “Company”) is furnishing a corporate presentation, attached as Exhibit 99.1 to this Current Report on Form 8-K, which the Company intends to use from time to time in meetings with investors and others beginning on January 9, 2017. The corporate presentation will also be available on the Company’s website at http://investor.assemblybio.com/index.cfm.

 

The information in this Item 7.01 and Exhibit 99.1 attached hereto is intended to be furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

 

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits:

 

The following exhibit relating to Item 7.01 shall be deemed furnished, and not filed:

 
     
Exhibit No.   Description
99.1   Assembly Biosciences, Inc. Corporate Presentation January 2017.

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

Assembly Biosciences, Inc.
 
   
By:   /s/  Derek Small
    Derek Small
    President and Chief Executive Officer

Date: January 9, 2017

 

 

 

  

EXHIBIT INDEX

 

 
     
Exhibit No.   Description
99.1   Assembly Biosciences, Inc. Corporate Presentation January 2017.